SPDR S&P Biotech ETF $XBI Shares Sold by Employees Retirement System of Texas

Employees Retirement System of Texas lessened its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 725,272 shares of the exchange traded fund’s stock after selling 13,000 shares during the period. Employees Retirement System of Texas’ holdings in SPDR S&P Biotech ETF were worth $88,432,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the business. JPMorgan Chase & Co. boosted its holdings in SPDR S&P Biotech ETF by 27.3% in the third quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock valued at $1,356,582,000 after purchasing an additional 2,900,633 shares in the last quarter. Assetmark Inc. increased its stake in SPDR S&P Biotech ETF by 1,042,265.6% in the fourth quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after purchasing an additional 635,782 shares during the last quarter. Greenwoods Asset Management Hong Kong Ltd. acquired a new stake in SPDR S&P Biotech ETF during the third quarter worth approximately $55,613,000. Ameriprise Financial Inc. raised its holdings in SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares in the last quarter. Finally, Main Street Research LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $43,959,000.

SPDR S&P Biotech ETF Trading Up 1.3%

Shares of NYSEARCA:XBI opened at $133.35 on Wednesday. The firm has a 50 day simple moving average of $130.23 and a 200-day simple moving average of $125.49. SPDR S&P Biotech ETF has a twelve month low of $78.06 and a twelve month high of $139.19. The company has a market capitalization of $8.51 billion, a PE ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.